Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of PF-08049820 Formulations Under Fasted and Fed Conditions and Effect of Rabeprazole in Healthy Adults
NCT07597928Phase 1Completed
- Sponsor
- Pfizer
- Start
- May 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PF-08049820 (7 arms), sponsored by Pfizer. Primary endpoints: Area under the concentration-time curve from time zero to the time of the last quantifiable concentration at Day 24, Area under the curve from time zero to extrapolated infinite time at Day 24 and 1 more. Started May 2026; status: completed.
02
Drugs
PF-08049820
Beyond the preview
Go deeper on NCT07597928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07597928.